Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07337109 · ClinicalTrials.gov registry record
A Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers
A clinical trial of Dentin Hypersensitivity, sponsored by HALEON.
- Recruiting
- Registry status
- 375
- Enrollment target
- 1
- Study location
NCT07337109 is a study of Dentin Hypersensitivity that is actively recruiting participants, run by HALEON. The registered enrollment target is 375 participants, above the 294-participant average among 4 other Dentin Hypersensitivity trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07337109, a study of Dentin Hypersensitivity, is actively recruiting participants, sponsored by HALEON.
- RECRUITING
- Registry status
- 375 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to characterize changes in Oral-Health-Related Quality of Life (OHrQoL), as measured by the Dentin Hypersensitivity Experience Questionnaire (DHEQ) over a 12-month period.
Conditions Studied
Study Locations (1)
Nevada
- Citruslabs (Virtual Site) - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2025-12-16 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07337109
The ClinicalTrials.gov registry entry for NCT07337109 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 294-participant average among 4 other Dentin Hypersensitivity trials with a reported enrollment target (28% higher). The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dentin Hypersensitivity appearing as the primary indexed condition, and to 0 interventions.
NCT07337109 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT07337109 about?
NCT07337109 is a clinical study titled "A Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers". The primary purpose of this study is to characterize changes in Oral-Health-Related Quality of Life (OHrQoL), as measured by the Dentin Hypersensitivity Experience Questionnaire (DHEQ) over a 12-month period.
What is the current status of trial NCT07337109?
This trial is currently recruiting. The enrollment target is 375 participants. The study started on 2025-12-16. Estimated completion is 2027-04.
What conditions does trial NCT07337109 study?
This clinical trial studies the following conditions: Dentin Hypersensitivity.
Who is sponsoring clinical trial NCT07337109?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07337109 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dentin Hypersensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice
RECRUITING · Phase 3
-
A Study to Investigate the Tooth Whitening and Dentin Hypersensitivity Effectiveness of Two Experimental Toothpastes
RECRUITING · NA
-
A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity
COMPLETED · NA
-
A Comparison Study of Hypersensitivity Treatment
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.